Manage Alerts


    As of 10/23/2020

    52 Wk Avg$17.99$20.04-10.32%
    52 Wk High$19.47$21.39-7.27%
    52 Wk Low$11.50$14.56-21.53%
    Regular Distribution TypeManaged Distribution
    Distribution Rate7.25%
    Distribution Amount$0.1125
    Distribution FrequencyMonthly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    The Fundt's investment objective is to seek current income and long-term capital appreciation. The Fund's investment objective is a non-fundamental policy and may be changed by the Board of Trustees of the Fund upon 60 days' notice to shareholders. Under normal market conditions, the Fund expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industry, including equity securities, debt securities, and pooled investment vehicles.

    Capital Structure

    As of 10/23/2020

    Total Investment Exposure:$1,075.786M
    Total Common Assets:$850.786M
    Common Shares Outstanding:41,340,447

    As of 10/22/2020

    Preferred Share Assets:
    Total Debt (USD): $225.000M
    Regulatory Leverage (USD): $225.000M
    Effective Leverage (USD): $225.000M
    Effective Leverage (%): 20.91%
    Annual Expense Ratios

    As of 9/30/2020

      Per Common Share
    Management Fees1.28%
    Other Expenses:0.23%
    Baseline Expense: N/A
    Interest Expense:0.91%
    Total: 2.42%
    Fund Management

    Fund Sponsor
    Tekla Capital Management LLC

    Portfolio Managers
    Christoper F. Brinzey, Frank T. Gentile, Jason C. Akus, Daniel R. Omstead

    Category: Equity-Sector Equity
    Ticker: THQ
    NAV Ticker: XTHQX
    Average Daily Volume (shares): 153,110
    Average Daily Volume (USD): $2.680M
    Inception Date: 7/28/2014
    Inception Share Price: $20.00
    Inception NAV: $19.06
    Tender Offer: No
    Term: No
    Fiscal Year End: September 30
    Third Party Links & Reports


    As of 10/23/2020

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 3/31/2020
    Annualized Distribution Rate on NAV:
    As of 10/23/2020
    Total Return on NAV (12 months):
    As of 10/23/2020
    Avg. Portfolio Coupon:
    As of 10/23/2020
    Total % Portfolio Effectively Leveraged:
    As of 10/23/2020

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 10/23/2020

    PeriodAvg Discount
    6 Month-10.52%
    1 Year-10.32%
    3 Year-9.87%
    5 Year-9.71%

    As of 10/23/2020

    3 Month1.72
    6 Month0.55
    1 Year0.23
    Pricing History
    Date NAV Premium / Discount


    Calendar Year Total Returns

    As of 9/30/2020
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 9/30/2020
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Average Coupon:
    As of 10/23/2020
    Number of Holdings:
    As of 6/30/2020
    Annual Portfolio Turnover:
    As of 9/30/2020
    Asset Allocation

    As of 6/30/2020 reported by Fund Sponsor

    Top Sectors

    As of 6/30/2020 reported by Fund Sponsor

    Defensive (Super Sector)72.19%
    Corporate (Super Sector)17.29%
    Corporate Bond16.11%
    Cash Equivalents (Super Sector)5.85%
    Cash Equivalents5.85%
    Real Estate4.64%
    Cyclical (Super Sector)4.64%
    Preferred Stock1.18%
    Top Holdings

    As of 6/30/2020 reported by Fund Sponsor

    HoldingValue% Portfolio
    Johnson & Johnson$70.66M6.77%
    UnitedHealth Group Inc$54.69M5.24%
    Merck & Co Inc$44.10M4.23%
    AbbVie Inc$33.80M3.24%
    Bristol-Myers Squibb Company$33.02M3.17%
    Pfizer Inc$32.08M3.08%
    Abbott Laboratories$31.47M3.02%
    CVS Health Corp$26.18M2.51%
    Amgen Inc$24.77M2.37%
    Thermo Fisher Scientific Inc$24.59M2.36%
    Credit Quality

    As of 6/30/2020 reported by Fund Sponsor

    Maturity Breakdown

    As of 6/30/2020 reported by Fund Sponsor

    Country Allocation

    As of 6/30/2020 reported by Fund Sponsor

    Country% Portfolio
    United States - Equity0.10%
    United Kingdom - Equity0.00%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.


    Distribution type sourced from Morningstar. In general, managed distributions may be sourced from net investment income, realized gains and return of capital. CEFConnect.com does not undertake to disclose specific information about closed-end fund distribution sources. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.